Histrelin Implant (CPP) and Ranibizumab Intraocular
Determining the interaction of Histrelin Implant (CPP) and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: histrelin
Brand name: Supprelin LA, Vantas, Supprelin
Synonyms: Histrelin (implant), Histrelin
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Histrelin Implant (CPP)-Ranibizumab ophthalmic
- Histrelin Implant (CPP)-Ranitidine
- Histrelin Implant (CPP)-Ranitidine Capsule
- Histrelin Implant (CPP)-Ranitidine Hydrochloride
- Histrelin Implant (CPP)-Ranitidine Injection
- Histrelin Implant (CPP)-Ranitidine Suspension
- Ranibizumab Intraocular-Histrelin Implant (Prostate Cancer)
- Ranibizumab Intraocular-Histrelin Subcutaneous
- Ranibizumab Intraocular-Histuss PD
- Ranibizumab Intraocular-Hivid
- Ranibizumab Intraocular-Hizentra
- Ranibizumab Intraocular-HMS